Showing 61 - 70 of 255
Persistent link: https://www.econbiz.de/10003712037
Persistent link: https://www.econbiz.de/10003527916
Persistent link: https://www.econbiz.de/10003555035
Persistent link: https://www.econbiz.de/10003511733
Persistent link: https://www.econbiz.de/10003960292
Wer bezahlt was und an wen? - dies ist eine zentrale Frage im deutschen Gesundheitswesen. Sie muss beantwortet werden, wenn durch zukünftige Reformen eine dauerhafte Finanzierung gewährleistet werden soll. Die Mittelaufbringung, sei es über Steuern, Sozialversicherungsbeiträge,...
Persistent link: https://www.econbiz.de/10009492620
compares the health care systems of France, Germany, Japan and the Netherlands. Due to the complexity of the different …
Persistent link: https://www.econbiz.de/10009492624
Rising costs in pharmaceutical expenditure have become a major concern for policy makers in Germany over the last years …. Therefore the pharmaceutical market in Germany has been increasingly targeted by different kinds of regulations, focussing both …
Persistent link: https://www.econbiz.de/10009492625
Leistungsanbietern vorsieht. Im Ergebnis soll der Wettbewerb zwischen den Krankenversicherungen verstärkt werden. Die Einführung von …
Persistent link: https://www.econbiz.de/10009492627
This chapter illustrates the contribution which could be made to realising the Lisbon Strategy of the European Union for growth and jobs by innovative healthcare policy favouring a preventive orientation of healthcare. The prevention and control of risk factors for chronic diseases, as well as...
Persistent link: https://www.econbiz.de/10009500541